skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: A new Drosophila model of Ubiquilin knockdown shows the effect of impaired proteostasis on locomotive and learning abilities

Journal Article · · Experimental Cell Research
;  [1]; ;  [1]
  1. Department of Applied Biology Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto 606-8585 (Japan)

Highlights: • New Drosophila ubiquilin knockdown model for neurological disorders was developed. • Depletion of dUbqn in CNS induced an accumulation of polyubiquitylated proteins. • Depletion of dUbqn in CNS caused structural defects in NMJ and brain in larvae. • Defects in NMJ and brain correlated with disabilities in locomotion and learning. Ubiquilin (UBQLN) plays a crucial role in cellular proteostasis through its involvement in the ubiquitin proteasome system and autophagy. Mutations in the UBQLN2 gene have been implicated in amyotrophic lateral sclerosis (ALS) and ALS with frontotemporal lobar dementia (ALS/FTLD). Previous studies reported a key role for UBQLN in Alzheimer's disease (AD); however, the mechanistic involvement of UBQLN in other neurodegenerative diseases remains unclear. The genome of Drosophila contains a single UBQLN homolog (dUbqn) that shows high similarity to UBQLN1 and UBQLN2; therefore, the fly is a useful model for characterizing the role of UBQLN in vivo in neurological disorders affecting locomotion and learning abilities. We herein performed a phenotypic and molecular characterization of diverse dUbqn RNAi lines. We found that the depletion of dUbqn induced the accumulation of polyubiquitinated proteins and caused morphological defects in various tissues. Our results showed that structural defects in larval neuromuscular junctions, abdominal neuromeres, and mushroom bodies correlated with limited abilities in locomotion, learning, and memory. These results contribute to our understanding of the impact of impaired proteostasis in neurodegenerative diseases and provide a useful Drosophila model for the development of promising therapies for ALS and FTLD.

OSTI ID:
23082506
Journal Information:
Experimental Cell Research, Vol. 362, Issue 2; Other Information: Copyright (c) 2017 Elsevier Inc. All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0014-4827
Country of Publication:
United States
Language:
English

Similar Records

ALS/FTLD-linked TDP-43 regulates neurite morphology and cell survival in differentiated neurons
Journal Article · Thu Aug 01 00:00:00 EDT 2013 · Experimental Cell Research · OSTI ID:23082506

The N-terminus of TDP-43 promotes its oligomerization and enhances DNA binding affinity
Journal Article · Fri Aug 24 00:00:00 EDT 2012 · Biochemical and Biophysical Research Communications · OSTI ID:23082506

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Journal Article · Fri Dec 22 00:00:00 EST 2006 · Biochemical and Biophysical Research Communications · OSTI ID:23082506